DOSSIER · 13F Holders · Q3 2026
ATTO

ATTOVIA THERAPEUTICS INC

7 institutions still hold ATTOVIA THERAPEUTICS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 04987L102·7 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
$32M
visible holders
Holders
7
filers reporting
Concentration
58.36%
Sanofi #1
top holder share
AI Holders Summary · Q3 2026

7 institutions reported ATTO in Q3 2026. Sanofi leads at 58.4% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Sanofi
CIK 0001121404
$19M1.1M2.95%Q3 2026
02
FMR LLC
CIK 0000315066
$6M324K0.00%Q3 2026
03
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$4M206K0.00%Q3 2026
04
UBS Group AG
CIK 0001610520
$3M184K0.00%Q3 2026
05
Squarepoint Ops LLC
CIK 0001642575
$732K43K0.00%Q3 2026
06
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
CIK 0001536186
$254K15K0.02%Q3 2026
07
CITIGROUP INC
CIK 0000831001
$21K1K0.00%Q3 2026
Insiders at ATTOVIA THERAPEUTICS INC
Walsh Colin →Sanofi →